Biotech Mega Convention Is Big Business For PhiladelphiaThe 15,000 attendees will help the city realize a more than $43 million economic impact during their stay.
Merck To Manufacture Potential Ebola Vaccine Merck & Co., one of the world's top developers and sellers of vaccines, has entered a partnership with a small drug developer to research and manufacture a potential Ebola vaccine now in initial patient testing.
Merck Announces Another Round Of Layoffs On the heels of more than 650 job cuts at its West Point manufacturing and research plant in late 2013 and earlier this year, Merck plans to let go another 600 employees by the end of August.
Merck Recalling Combination Cholesterol DrugDrugmaker Merck & Co. is recalling a combination cholesterol drug, wiping out the entire U.S. stock, due to packaging defects that could reduce effectiveness.
Drugmaker Merck To Cut 8,500 More JobsDrugmaker Merck says it plans to reduce its global workforce by another 8,500 jobs as part of a plan to cut its annual costs by about $2.5 billion by the end of 2015.
FDA Reviewing Merck’s Allergy Therapy Meant To Reduce Allergic Reactions Drugmaker Merck & Co. says the Food and Drug Administration is reviewing its second application to sell a new type of allergy treatment meant to gradually reduce allergic reactions over time, rather than just relieving sneezing, itching and other symptoms temporarily.
Earl “The Pearl” Monroe Teams With Merck In Fight Against DiabetesBasketball legend Earl “The Pearl” Monroe is teaming up with Merck on the Diabetes Restaurant Month program to challenge restaurants in Philadelphia to create diabetes-friendly menu items which are also heart healthy.
Merck Makes Massive Donation To Natural Products Library In DoylestownThe research arm of the Hepatitis B Foundation in Bucks County is on the receiving end of one of the world’s largest natural products libraries thanks to a donation from pharma giant Merck.
Study Examines Benefits Of HPV Vaccine For Men and BoysAfter three years, the researchers found the vaccine reduced HPV infection by as much as 90-percent in those who were HPV negative at the start of the testing.